12 analysts have recently updated their ratings and price targets for Morgan Stanley (NYSE:MS), showing a mix of bullish and indifferent stances with no bearish views. The average 12-month price target is now $97.92, slightly down from $98.90. Analyst actions include both upgrades and downgrades, reflecting a nuanced view of the company's prospects. Morgan Stanley's financial performance shows strong revenue growth and net margin, but challenges in ROE, ROA, and a high debt-to-equity ratio.